celecoxib has been researched along with threonine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demetris, AJ; Han, C; Leng, J; Wu, T | 1 |
1 other study(ies) available for celecoxib and threonine
| Article | Year |
|---|---|
The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspase 9; Caspases; Celecoxib; Cell Death; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Chromones; Cyclooxygenase 2; Cytochromes c; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Immunoassay; Immunohistochemistry; Isoenzymes; Membrane Proteins; Microscopy, Fluorescence; Morpholines; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Sulfonamides; Threonine; Time Factors | 2004 |